Mechanism of the cleavage specificity of Alzheimer’s disease γ-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein

  • Stefan F. Lichtenthaler
    Center for Molecular Biology, University of Heidelberg, Im Neuenheimer Feld 282, D-69120 Heidelberg, Germany; Laboratory for Mass Spectrometry, The Rockefeller University, New York, NY 10021; and Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia
  • Rong Wang
    Center for Molecular Biology, University of Heidelberg, Im Neuenheimer Feld 282, D-69120 Heidelberg, Germany; Laboratory for Mass Spectrometry, The Rockefeller University, New York, NY 10021; and Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia
  • Heike Grimm
    Center for Molecular Biology, University of Heidelberg, Im Neuenheimer Feld 282, D-69120 Heidelberg, Germany; Laboratory for Mass Spectrometry, The Rockefeller University, New York, NY 10021; and Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia
  • Sacha N. Uljon
    Center for Molecular Biology, University of Heidelberg, Im Neuenheimer Feld 282, D-69120 Heidelberg, Germany; Laboratory for Mass Spectrometry, The Rockefeller University, New York, NY 10021; and Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia
  • Colin L. Masters
    Center for Molecular Biology, University of Heidelberg, Im Neuenheimer Feld 282, D-69120 Heidelberg, Germany; Laboratory for Mass Spectrometry, The Rockefeller University, New York, NY 10021; and Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia
  • Konrad Beyreuther
    Center for Molecular Biology, University of Heidelberg, Im Neuenheimer Feld 282, D-69120 Heidelberg, Germany; Laboratory for Mass Spectrometry, The Rockefeller University, New York, NY 10021; and Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia

この論文をさがす

抄録

<jats:p> Proteolytic processing of the amyloid precursor protein by β-secretase yields A4CT (C99), which is cleaved further by the as yet unknown γ-secretase, yielding the β-amyloid (Aβ) peptide with 40 (Aβ <jats:sub>40</jats:sub> ) or 42 residues (Aβ <jats:sub>42</jats:sub> ). Because the position of γ-secretase cleavage is crucial for the pathogenesis of Alzheimer’s disease, we individually replaced all membrane-domain residues of A4CT outside the Aβ domain with phenylalanine, stably transfected the constructs in COS7 cells, and determined the effect of these mutations on the cleavage specificity of γ-secretase (Aβ <jats:sub>42</jats:sub> /Aβ <jats:sub>40</jats:sub> ratio). Compared with wild-type A4CT, mutations at Val-44, Ile-47, and Val-50 led to decreased Aβ <jats:sub>42</jats:sub> /Aβ <jats:sub>40</jats:sub> ratios, whereas mutations at Thr-43, Ile-45, Val-46, Leu-49, and Met-51 led to increased Aβ <jats:sub>42</jats:sub> /Aβ <jats:sub>40</jats:sub> ratios. A massive effect was observed for I45F (34-fold increase) making this construct important for the generation of animal models for Alzheimer’s disease. Unlike the other mutations, A4CT-V44F was processed mainly to Aβ <jats:sub>38</jats:sub> , as determined by mass spectrometry. Our data provide a detailed model for the active site of γ-secretase: γ-secretase interacts with A4CT by binding to one side of the α-helical transmembrane domain of A4CT. Mutations in the transmembrane domain of A4CT interfere with the interaction between γ-secretase and A4CT and, thus, alter the cleavage specificity of γ-secretase. </jats:p>

収録刊行物

被引用文献 (13)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ